Skip to content

Aidoc

Paid

FDA-cleared radiology AI that flags critical findings across CT, MRI, and X-ray in real time

What is Aidoc?

Aidoc is one of the most widely deployed radiology AI companies in the world, with its FDA-cleared algorithms installed in over 1,000 hospitals and imaging centers across North America, Europe, and Israel. The company's core product is an always-on AI layer that analyzes CT scans, MRIs, and X-rays the moment they are acquired, automatically flagging time-critical findings — such as intracranial hemorrhage, pulmonary embolism, cervical spine fractures, and large vessel occlusion strokes — and prioritizing them in the radiologist's worklist. Rather than replacing radiologists, Aidoc shortens the time between imaging and diagnosis, which matters most in emergency and stroke care where every minute affects outcomes. Aidoc's platform, aiOS, is modular: hospitals can turn on individual FDA-cleared algorithms for specific clinical indications and integrate results into PACS, EHR, and care coordination tools. Aidoc also powers care-coordination workflows that notify stroke teams, interventionalists, and on-call physicians instantly when the AI detects a critical finding. The company has raised over $250 million, has dozens of FDA clearances, and is considered one of the two or three dominant enterprise radiology AI vendors. Aidoc is sold to health systems through custom enterprise contracts — there is no free version and no self-serve access.

⚡ Quick Verdict

Best for

Hospitals and imaging centers that want FDA-cleared AI triage for time-critical radiology findings

Not ideal for

Solo radiologists or small practices without PACS integration capacity

Starting price

Enterprise contracts · No published pricing

Free plan

No — regulated medical device software

Key strength

Breadth of FDA-cleared algorithms and real-world deployment scale

Limitation

Complex integration and enterprise procurement required

Bottom line: Aidoc scores 4.5/5 — the clear leader in enterprise radiology AI for time-critical findings, with one of the largest FDA-cleared portfolios in the market.

Pricing

Contact sales: Aidoc does not publish pricing. It is sold to hospitals and imaging centers as an enterprise platform subscription, typically priced per algorithm, per facility, or per scan volume. Large health systems commonly pay six to seven figures annually for a bundle of FDA-cleared algorithms plus the aiOS integration layer and care-coordination tools.

Modular algorithms: Customers can start with a single high-value module (e.g., intracranial hemorrhage detection for the ED) and expand to additional indications like pulmonary embolism, C-spine fracture, and incidental findings over time.

Trials: Aidoc offers structured pilots with select health systems to validate clinical impact before scaling — not a self-serve free trial.

Key Features

  • FDA-cleared algorithms across CT, MRI, and X-ray
  • Real-time flagging of intracranial hemorrhage, PE, stroke, fractures
  • aiOS platform for unified multi-algorithm orchestration
  • PACS and EHR integration with major vendors
  • Worklist prioritization to speed urgent reads
  • Care coordination notifications for stroke and PE teams
  • Hospital-grade audit trails and performance dashboards
  • Dozens of FDA clearances covering multiple clinical indications

Pros & Cons

Pros

  • One of the largest portfolios of FDA-cleared radiology AI algorithms
  • Deployed at 1,000+ hospitals with extensive real-world validation
  • Directly tied to faster diagnosis and treatment for critical findings
  • Unified aiOS platform simplifies multi-algorithm deployment

Cons

  • Enterprise-only with no published pricing
  • Requires PACS/EHR integration work to deploy
  • Not a replacement for radiologists — still a decision-support tool
✅ Pricing verified April 2026 · ✅ Independently reviewed · ✅ Scoring methodology

FAQ

What exactly does Aidoc do?

Aidoc runs FDA-cleared AI algorithms against imaging studies (CTs, MRIs, X-rays) immediately after acquisition and flags findings that are likely time-critical — things like intracranial hemorrhage, pulmonary embolism, cervical spine fracture, and large vessel occlusion. Flagged studies get prioritized on the radiologist's worklist, and care-team notifications can be triggered so stroke, ED, and interventional teams know immediately. The radiologist still reviews and signs out the case.

Is Aidoc FDA cleared?

Yes. Aidoc has received dozens of FDA 510(k) clearances across multiple clinical indications and imaging modalities. That makes it one of the largest portfolios of cleared radiology AI in the US market. Clearances cover specific use cases such as ICH, PE, C-spine fracture, and incidental pulmonary nodules. Each algorithm is cleared independently and has its own intended use and performance data.

Does Aidoc replace radiologists?

No. Aidoc is a triage and decision-support tool, not an autonomous diagnostic system. Radiologists still read and sign out every study. What Aidoc changes is the order in which studies are read — critical findings surface at the top of the worklist instead of waiting in the queue — and how quickly downstream care teams are notified. Hospitals typically cite faster time to diagnosis and intervention as the main benefit.

How does Aidoc integrate with PACS and EHR?

Aidoc integrates with major PACS vendors (GE, Philips, Sectra, Intelerad, Visage, and others) and EHR systems like Epic. The aiOS platform receives studies from the modality or PACS, runs the relevant algorithms, and pushes results back as worklist priority flags, overlays, and structured outputs. Care-coordination workflows use standard messaging (Epic Monitor, HL7, or the Aidoc app) so on-call teams are paged automatically.

How much does Aidoc cost?

Aidoc does not publish pricing. Contracts are enterprise-only and depend on algorithm bundle, facility count, scan volume, and integration scope. Health systems commonly spend six to seven figures annually on a full deployment. Smaller facilities can start with a single high-impact module (such as ICH for the ED) and expand over time. All contracts go through Aidoc sales with a structured clinical validation pilot.

Aidoc vs Viz.ai — which is better?

Both are enterprise radiology AI leaders, but they differ in focus. Viz.ai is best known for large vessel occlusion stroke detection and end-to-end stroke care coordination. Aidoc offers a broader multi-algorithm platform across ICH, PE, fractures, and incidental findings, with strong worklist prioritization across the whole radiology department. Hospitals sometimes run both, but most standardize on one as their primary enterprise imaging AI platform.

📋 Good to know

Setup

Contact Aidoc sales for a demo and pilot. Enterprise deployments include integration and training.

Privacy

Enterprise security posture with BAAs or DPAs as appropriate. SOC 2 / HIPAA / GDPR coverage depending on product.

When to upgrade

Hospitals and imaging centers that want FDA-cleared AI triage for time-critical radiology findings.

Learning curve

Enterprise-grade training and onboarding typically included in contracts.

Explore more

Compare Aidoc with alternatives

Aidoc vs SermoFull comparison → Aidoc vs MerativeFull comparison → Aidoc vs PathologyWatchFull comparison → Aidoc vs TempusFull comparison →
📝 Report incorrect info about Aidoc